国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Critical Analysis of Charakokta Mahakashaya in the Management of Respiratory Allergic Disorders (RAD)

Nilesh Ingle, NishaKumari Ojha and Abhimanyu Kumar

Respiratory allergic disorders are the most common allergic manifestation that is encountered in paediatric age group. Grievance of this problem is stated by statistical view which shows 5-20% of the paediatric population are sufferers of Respiratory Allergic Disorders (RAD). Acharya charak mentions a variety of hetus for this type of disease that incorporates Rajasa (from dust), Dhooma (smoke), Rukshaanna (dry food), and Vishamashan (irregular diet). These are important causative factors that can be attributed to environment and diet. Because respiratory allergies occur mostly due to hyper responsivenessto these factors in the form of histamine release and activation of mast cells, treatment is aimed towards anti-histaminic and mast cell stabilising agent. Ayurveda has a large number of drugs that can act as anti-histaminic or mast cell stabilising agents. The present paper is focused on Charakokta mahakashaya to determine the role of Shwashar Mahakashaya, Kasahar mahakashaya and Vishaghna mahakashaya and their dravyas for management of RAD. The paper attributes to the critical analysis of Shwashhar, Kasahar, and Vishaghna mahakashaya to elicit their pharmacological actions based on various experimental and clinical studies.